ClonOrgan

About:

ClonOrgan is a developer of xenotransplantation pig.

Top Investors: Dingzhou Yichuang, Royal Sea Capital

Description:

ClonOrgan has developed a technology to humanize pig cells that will grow into human-compatible organs. The business specializes in xenotransplantation and has a one-stop R&D platform that includes raising gene-edited pigs, preclinical testing, and breeding. It is dedicated to addressing the critical shortage of clinical organ transplantation and creating the organ factory of the future. ClonOrgas was established in 2005 in Chengdu, Sichuan.

Total Funding Amount:

$8.35M

Headquarters Location:

Chengdu, Sichuan, China

Founded Date:

2005-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-07-05

IPO Status:

Private

Industries: